India · Delayed Price · Currency is INR Mukka Proteins Statistics
Total Valuation
Mukka Proteins has a market cap or net worth of INR 7.98 billion. The enterprise value is 15.46 billion.
| Market Cap | 7.98B |
| Enterprise Value | 15.46B |
Important Dates
The last earnings date was Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 300.00M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.61% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 73.33% |
| Owned by Institutions (%) | 3.97% |
| Float | 80.00M |
Valuation Ratios
The trailing PE ratio is 11.49.
| PE Ratio | 11.49 |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 1.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 22.27 |
| EV / Sales | 0.87 |
| EV / EBITDA | 10.36 |
| EV / EBIT | 11.76 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.47 |
| Debt / EBITDA | 5.28 |
| Debt / FCF | -3.12 |
| Interest Coverage | 2.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.71% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 56.32M |
| Profits Per Employee | 2.21M |
| Employee Count | 314 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Mukka Proteins has paid 260.27 million in taxes.
| Income Tax | 260.27M |
| Effective Tax Rate | 25.99% |
Stock Price Statistics
The stock price has decreased by -3.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -3.94% |
| 50-Day Moving Average | 24.02 |
| 200-Day Moving Average | 23.54 |
| Relative Strength Index (RSI) | 66.43 |
| Average Volume (20 Days) | 65,941 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mukka Proteins had revenue of INR 17.68 billion and earned 694.29 million in profits. Earnings per share was 2.33.
| Revenue | 17.68B |
| Gross Profit | 3.46B |
| Operating Income | 1.30B |
| Pretax Income | 1.00B |
| Net Income | 694.29M |
| EBITDA | 1.48B |
| EBIT | 1.30B |
| Earnings Per Share (EPS) | 2.33 |
Balance Sheet
The company has 604.29 million in cash and 7.79 billion in debt, with a net cash position of -7.19 billion.
| Cash & Cash Equivalents | 604.29M |
| Total Debt | 7.79B |
| Net Cash | -7.19B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.29B |
| Book Value Per Share | 16.70 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -1.11 billion and capital expenditures -1.38 billion, giving a free cash flow of -2.50 billion.
| Operating Cash Flow | -1.11B |
| Capital Expenditures | -1.38B |
| Depreciation & Amortization | 178.17M |
| Net Borrowing | 3.13B |
| Free Cash Flow | -2.50B |
| FCF Per Share | n/a |
Margins
Gross margin is 19.59%, with operating and profit margins of 7.34% and 3.93%.
| Gross Margin | 19.59% |
| Operating Margin | 7.34% |
| Pretax Margin | 5.66% |
| Profit Margin | 3.93% |
| EBITDA Margin | 8.35% |
| EBIT Margin | 7.34% |
| FCF Margin | n/a |
Dividends & Yields
Mukka Proteins does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.61% |
| Shareholder Yield | 0.61% |
| Earnings Yield | 8.70% |
| FCF Yield | -31.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |